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ABSTRACT
This report summarizes the activities and major accomplishments for the Idaho National
Laboratory Advanced Radiotherapy Research Program for calendar year 2004. Topics
covered include boron analysis in biological samples, computational dosimetry and
treatment planning software development, medical neutron source development and
characterization, and collaborative dosimetry studies at the RA-1 facility in Buenos
Aires, Argentina.
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INTRODUCTION AND EXECUTIVE SUMMARY
The Idaho National Laboratory (INL) Advanced Radiotherapy Research Program
completed its 18
th
year under the sponsorship of the U.S. Department of Energy (DOE),
Office of Science (SC). This report includes detailed articles summarizing major INL
activities and accomplishments during calendar year 2004.
As a result of various realignments over the few years, the scope of the INL program has
grown beyond its original focus on neutron capture therapy (NCT) to encompass the
development of enabling technologies for a significantly broader range of emerging
radiotherapy modalities. The primary mission of the program, which has featured a
comprehensive network of domestic and international collaborations over the last few
years, is the performance of applied research and technology development to enable the
application of emerging radiotherapy modalities that show promise for improved
treatment of cancer and possibly other diseases. Of particular interest is a new activity
focused on collaboration with The University of California at Davis (UCD), Lawrence
Livermore National Laboratory (LLNL), and several other partners in the field of
advanced multimodality computational dosimetry and treatment planning software
development. Additional tasks involving analytical chemistry, small-animal boron agent
screening studies, and development of neutron sources and benchmark dosimetry data for
NCT as well as for fast-neutron therapy (FNT) also achieved significant milestones
during the year.
Essentially all of the activities encompassed by the INL program are performed in close
collaboration with several other institutions having similar interests. Where a benefit to
the U.S. effort is realized, the INL has also maintained formal cooperative arrangements
with international collaborators, specifically in The Netherlands, Finland, Sweden,
Russia, and, of particular recent interest, Argentina. These collaborative arrangements
have resulted in substantial leveraging of DOE-SC funding in essentially all areas of the
overall INL program.
The historical INL role as a center for quantitative boron analysis and radiation treatment
planning software development and deployment continued during 2004. Biological
samples and boron agent samples submitted to the INL by federally supported NCT
research organizations were analyzed for boron content in accordance with well-
established standards, and the results were reported back to the submitting organizations.
The internationally recognized INL SERA (Simulation Environment for Radiotherapy
Applications) computational dosimetry and treatment planning software system
continued to be supported during the year, and new national and international licensees
continued to join the SERA user community. NCT and FNT research centers worldwide
continue to serve as benchmarking and testing institutions for SERA, providing
extremely valuable feedback and suggestions for improvement although the code has
essentially stabilized in its final form at this point. A planned task during the upcoming
2year involved finalizing the documentation for SERA in an externally releasable form
and assembling a final validated code distribution package per applicable DOE
distribution requirements. The final package will be submitted for unrestricted
distribution via the DOE Radiation Shielding Information Computational Center
(RSICC) at Oak Ridge National Laboratory. The SERA Internet site will be actively
maintained through FY 2005, with a referral to RSICC for distribution thereafter. This
will complete the SERA treatment planning development project, which has been
supported by DOE-SC since 1996.
With the completion of SERA, the developmental focus is now on the new MINERVA
(Modality Inclusive Environment for Radiotherapeutic Variable Analysis) multimodality
radiotherapy computational dosimetry treatment planning system. This effort involves a
broad collaboration as noted above. This project takes advantage of the many benefits of
using the Java programming language to create a "next-generation" modality independent
system for a wide variety of research applications in essentially all traditional and
emerging fields of radiotherapy.
INL also continued its efforts toward the development and benchmarking of neutron
sources useful for NCT, FNT, and NCT-augmented FNT. This has involved
collaborations with the University of Washington (UW) fast-neutron radiotherapy
program, the Washington State University (WSU) Nuclear Radiation Center and School
of Veterinary Medicine, the University of Essen (Germany) and, of particular interest
during the past year, the neutron radiotherapy program at the Fermi National Accelerator
Laboratory. This effort has a focus on providing high-quality benchmark data for
validation of advanced 3D Monte Carlo based treatment planning systems, such as SERA
and MINERVA, as well as others under development elsewhere. In addition,
construction of a new epithermal neutron beam facility for preclinical research at WSU
was completed during the year, with the first demonstration of the thermalized beam
capability in November. Final characterization of both the thermal and epithermal beams
per the currently emerging international standard will be conducted during 2005.
Finally, in addition to the domestic NCT activities supported at the INL by DOE-SC, INL
researchers continued a very fruitful collaboration with the National Atomic Energy
Commission of Argentina (CNEA) in the areas of NCT beam dosimetry and small-animal
radiobiology. This collaboration is partially supported by the DOE National Nuclear
Energy Security Agency (NNSA) with additional in-kind contributions from an INL
CRADA (Cooperative Research and Development Agreement) partner, Neutron
Therapies, LLC.
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DETERMINATION OF BORON IN BIOLOGICAL SAMPLES
During calendar year (CY) 2004, 180 new samples were received for analysis by
inductively coupled plasma atomic emission spectroscopy (ICP-AES) using standardized
procedures established by INL scientists. With additional Quality Assurance (QA)
samples, the total number of samples analyzed came to 211. Of the samples received, 25
were from dogs and/or rodents from Boron Neutron Capture Therapy and related
programs in Dr. P. Gavin’s group at Washington State University (WSU), 26 were of
stock solutions to be sent to WSU and assorted other preparations from Dr. F.
Hawthorne’s group at University of California, Los Angeles (UCLA), and 129 were from
the University of California, San Francisco (UCSF). During CY 2005, a few samples are
expected from UCLA and from UCSF. ICP capabilities are now available at WSU to
support their local program, and only verification samples will be analyzed for them.
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INTRODUCTION
Development of the MINERVA (Modality-Inclusive Environment for Radiotherapeutic
Variable Analysis) general purpose treatment planning system continued at Montana
State University (MSU). Efforts focused on making the software, which is written
entirely in the Java programming language (Gosling 1996), more robust, more adaptable
to new hardware and software technologies, and easier to install on various computers.
Improved patient data management, internal code documentation and help system,
improved code configuration and management, and unit testing features were added to
MINERVA. Support was also extended to Windows XP. The development of a high-
speed, three-dimensional, neutron transport plugin is currently under development at
Idaho National Laboratory (INL), and a deformable registration method is being
developed at the BP Center for Visualization at the University of Colorado. The Patient,
Image, Model, and Analyze modules are also undergoing improvement.
DATA MANAGEMENT
While the goals of the data management system have not changed over the past year, the
implementation is completely new. The new implementation offers several advantages:
• The persistence layer is now multi-threaded, allowing multiple modules to use
the data system simultaneously. For example, while waiting for the geometry to
load, the user can edit and save an image set. The data to be persisted is defined
using Java’s metadata
a
facility on a per object basis. Each object defines which
fields should be persisted, along with the type of the field and other special
parameters that may be needed.
• The hibernate
b
object-relational mapper is used to generate the standard query
language (SQL) (ANSI X3.135, 1992) needed to communicate with the database
based on the information provided by the object's metadata. Hibernate also
abstracts the subtle differences between databases into database dialect classes.
This will allow many database engines to be easily supported by simply changing
the dialect being used.
• The database schema has been greatly simplified. Previously, the number of
tables in the database grew every time new objects were created for a patient.
After several patients had been stored, the number of tables was unmanageable.
Objects of the same type are now stored together, which allows the number of
tables to remain fixed after installation.
a
Java metadata: http://jcp.org/en/jsr/detail?id=175
b
hibernate: http://hibernate.org
5• The extensible markup language (XML)
c
part of the persistence system is also
being re-factored to use the defined metadata. By using the same metadata for all
data persisters, a change to the metadata will cascade and allow all persisters to
remain in-sync. This frees developers from maintaining cross-data source
compatibility by hand.
• The impact of adding a new data source to the system has been greatly reduced.
Adding a new data source consists of (a) implementing an interface to define how
the data maps onto the data source and (b) providing hooks for the new persister
into the system.
HELP SYSTEM
A help system was developed for MINERVA. This system provides an intuitive help
information facility that allows users to navigate, search, and display help information, as
shown in Figure 1. It can also help users learn how to use the system, reducing the initial
training time.
Figure 1. The MINERVA help system.
c
Coding of multimedia and hypermedia information-Part 8: XML notation for ISO/IEC 13522-5.
6The JavaHelp (Lewis 2000) extensions were used. JavaHelp is an extensible, platform-
independent help system that enables authors and developers to incorporate online help
into applets, applications, operating systems, and devices. The content pages are hyper-
text markup language (HTML) documents and contain text, links, and images.
The help system contains information about MINERVA, each of the modules, and the
molecular targeted therapy (MTR) plugin. The help system has a table of contents with a
tree structure displaying all the pages, an index, a glossary of terms, and a search
function. Information for additional plugins can be added as needed, as can tutorials.
Currently, the help system can be launched from any one of the MINERVA modules or
plugins. The system can also be made available online.
INSTALL SYSTEM
As the configuration of MINERVA utilizes more and new technologies, the installation
procedure becomes more complex. MINERVA itself can be run on any machine with
version 1.5 of the Java runtime environment (JRE). The JRE distributed by Sun
d
is
platform dependent, so a user must first download and install the appropriate JRE before
using the program. The various Java technologies employed by MINERVA require the
installation of Java archive (jar) files in the appropriate operating system dependent
location on the user’s file system.
An install wizard is being developed to facilitate the install process. Several commercial
products are being evaluated. Zero G
e
produces the “Install Anywhere” wizard. This can
be customized to our installation requirements, and will control the JRE used to run the
program. An installer will be provided for both users and developers. The developer
version of the installer will contain the interface documentation to build new plugins.
CODE CONFIGURATION AND MANAGEMENT
Up to this point, MINERVA and neutron transport model development have been done
using CVS
f
as the versioning system. CVS keeps track of old versions of the software
and merges changes made by different developers, which makes group development
easier. However, CVS does not provide a way to move a file or a directory while
keeping the change history with the moved file. Since the MINERVA directory structure
was going to be reorganized, the history would have become more difficult to access
under CVS. CVS allows finding the history only by knowing the original directory and
name, since as far as CVS is concerned, the old directory or file and the new one are
completely independent. The impending directory reorganization provided the motiva-
tion to move to a new versioning system, Subversion
g
. Subversion is being developed as
a CVS replacement, so it has most of the CVS features as well as new features. In
addition, the tool cvs2svn converts CVS repositories to Subversion repositories without
losing change history. For MINERVA development, the most important improvement in
Subversion is the ability to track changes as files and directories are moved, which was
used in the directory reorganization after the Subversion switch occurred.
d
Sun Microsystems Inc., Sunnyvale, CA
e
Zero G Software, Inc. San Francisco, CA
f
Concurrent Version Systems, freeware
g
For Example: Version Control with Subversion, C. Michael Pilato, B, et al., 2004, O’Reilly
7CODE FORMATTING
The Jalopy
h
Java formatting tool is being used with the MINERVA source code. This
tool will increase the readability and maintainability of the source code by creating a
uniform format throughout the source code. In addition, the code formatting allows
Javadoc comments to be generated automatically for classes and methods that have
previously been undocumented. This will allow new developers on the project to more
easily gain an understanding of the project, as well as showing current developers the
functionality of all the different pieces of the project. Jalopy is invoked using the
MINERVA build script to ensure that all code is formatted. It also integrates with the
Eclipse
i
and Netbeans
j
integrated development environments that are being used by the
majority of the MINERVA developers.
Jalopy has much more flexibility than the formatting tools built into various integrated
development environments, which allows everyone to use the same code formatter
regardless of their environment preference. Jalopy is also the only code formatter that
supports all the Java 5.0 constructs, which is crucial since a majority of the new code is
written using 5.0 constructs. Another feature of the formatter is that it contains the ability
to enforce the “Effective Java” rules. These rules have been published by Sun
Microsystems and should be followed in order to write the most effective source code.
UNIT TESTING
In order to improve software quality, provide accurate documentation, and improve
design in the software, unit tests
k
are being added to a unit test directory in the main trunk
of the repository. The structure of the test directory exactly mirrors that of the Minerva
source directory. Tests for classes in a specific source directory should be placed in the
corresponding test directory. For example, if a test is written for the class
minerva.tirade.patient.PatientUI, it should be placed in the test.tirade.patient package.
Unit testing allows small pieces of a system to be tested independently. Base tests
typically test a single class, while other tests use the base tests together to test larger
chunks of related code. This process can be repeated until whole subsystems or the entire
system is being tested together. If a problem arises after code changes are made, locating
the problem should be relatively easy and should quickly narrow the error to a specific
base test. This assumes that a sufficient number of tests have been written for the system.
The testing is actually done by JUnit
l
- a framework to assist developers in writing
repeatable tests. Writing a unit test is as simple as extending the JUnit TestCase class.
To define a test case:
1) implement a subclass of TestCase
2) define instance variables that store the state of the fixture
h
http://www.triemax.com/products/jalopy/manual/
i
http://www.eclispe.org
j
Netbeans is a Trademark of Sun Microsystems (http://www.netbeans.org)
k
http://www.onjava.com/pub/a/onjava/2003/04/02/javaxpckbk.html
l
http://junit.sourceforge.net
83) initialize the fixture state by overriding setUp
4) clean-up after a test by overriding tearDown.
Each test runs in its own fixture so there can be no side effects among test runs. An
example from the JUnit documentation follows:
public class MathTest extends TestCase
{
protected double fValue1;
protected double fValue2;
protected void setUp()
{
fValue1= 2.0;
fValue2= 3.0;
}
For each test, implement a method that interacts with the fixture. Verify the expected
results with assertions specified by calling assertTrue with a boolean.
public void testAdd()
{
double result= fValue1 + fValue2;
assertTrue(result == 5.0);
}
}
The tests have also been integrated into the Ant
m
build file, so they can easily be run at
any time. Ideally, a developer will test the subsystem as changes are made, and then run
the entire test suite before committing the changes back to the main development trunk.
DEFORMABLE REGISTRATION
The multimodal rigid image registration functionality in MINERVA is being extended to
perform non-rigid image registration. Initial steps included implementing a three-
dimensional (3D) volume viewer that will display both the reference and deformed image
sets simultaneously. The 3D viewer was implemented using OpenGL
n
replacing the
existing, primitive, Java3D based viewer in the registration module. The 3D viewer will
be the primary view of the image sets in the registration module with side-by-side 2D
slice displays also included. The motivation for this decision was the inherent difficulty
in interpreting 3D alignment from 2D slices. Work has also been completed to
automatically partition large volumes into smaller sub-volumes, allowing the display of
arbitrarily large volumes independent of the amount of memory on the graphics
hardware. The new 3D display also provides the basis for the calculation engine for the
non-rigid registration algorithm.
Several methods have been proposed to perform deformable, non-rigid registration.
Early non-rigid registration approaches used linear elasticity models (Christensen 1994,
m
http://access1.sun.com/techarticles/Ant.html
n
http://www.opengl.org
9Gee 1993, Evans 1991, Bajcsy 1989). The elasticity models enforce global smoothness
in the deformations and thus only allow small deformations. Christensen (Christensen
1996) then detailed the use of a partial differential equation based viscous fluid model to
control the deformations. The test image is a viscous fluid that flows to match the
reference image. Internal forces drive the deformations, and eventually those forces
subside due to the attenuation of viscous fluids. The viscous fluid model allows large
deformations while preserving topology. The drawback of this model is that it is
computationally expensive.
In an attempt to improve performance, the fluid flow modeling will be performed on the
graphics processing unit (GPU) rather than the central processing unit (CPU) (Kruger
2003, Lefohn 2003, Larsen 2001, Rumpf 2001, Strzodka 2001). The GPU provides a
parallel, single instruction, multiple data processor to perform floating point calculations.
The GPU has more bandwidth from the memory than the CPU, allowing the GPU to read
data faster than the CPU. Programming for the GPU is being accomplished using
OpenGL Shading Language
o
, a part of the OpenGL specification. An additional
advantage to using the GPU to perform the registration algorithm is that the user will get
visual progress updates as work is performed without additional computational expense.
Currently a proof of concept has been implemented which performs all image processing
in the 3D viewer on the GPU with a marked performance improvement. Implementation
of the fluid flow model is currently under way with preliminary results expected in late
FY 2005.
NEUTRON TRANSPORT MODULE (JART)
A univel geometry, neutral particle Monte Carlo transport code, written entirely in the
Java programming language, is under development for medical radiotherapy applications.
The code uses ENDF-VI
p
based continuous energy cross section data in a flexible XML
format. Full neutron-photon coupling, including detailed photon production and
photonuclear reactions, is included. Charged particle equilibrium is assumed within the
patient model so that detailed transport of electrons produced by photon interactions may
be neglected. External beam and distributed internal source descriptions for mixed
neutron-photon sources are allowed. Flux and dose tallies are performed on a univel
basis. A four-tap, shift-register-sequence random number generator (Ziff 1998) is used.
The solution space defined in the input is subdivided into univels, which are rectangular
parallelepipeds of uniform size. The transport method uses a three-dimensional variation
(Frandsen 2001, 1998a, 1998b) of Bresenham's line drawing algorithm (Bresenham
1965) for the ray tracing and particle tracking. Enhancements to the algorithm were
made to incorporate an improved method for calculating the total distance traveled across
each univel, which is a necessary quantity for calculating tallies on a univel basis.
The univel particle tracking algorithm is initialized with a location and a direction for
each particle. This initialization occurs at the birth of a particle and at each collision.
o
http://www.opengl.org/documentation/oglsl.html
p
Evaluated Nuclear Data File, compiled and maintained by the National Nuclear Data Center
(NNDC) at the Brookhaven National Laboratory (http://www.nndc.bnl.gov/exfor/endf00.htm)
10
The distance to collision is sampled in the normal fashion. At each univel boundary
crossing, a check is performed to see if a new material is encountered; if so, a new
distance to collision is sampled. Because of the uniform nature of the univels, the
distance traversed between boundary crossings along each spatial coordinate axis is a
constant and can be calculated from the initialization values and the univel dimensions.
This allows the use of (mostly) integer arithmetic to perform the particle tracking through
the univels. Univel material properties can be stored in an array and accessed quickly.
The tally calculation uses a basic track length estimator, which requires the distance
traveled through each univel. This distance is calculated during the univel particle
tracking. As noted above, the same distance is traveled between each parallel boundary
crossing along a given line. For example, each time a boundary is crossed along the x-
direction, the distance that has been traveled since the previous boundary crossing in this
direction can be calculated. The distance traveled in each univel is determined by
knowing that each time a particle crosses a univel boundary, it has traveled a known,
constant distance. This distance and a total distance are stored for each dimension, along
with an overall total distance. The overall total distance is the distance at the last
boundary crossing and is updated at each boundary crossing.
A two-dimensional example of this procedure is shown in Figure 2. The incremental
distance in the x-direction is denoted as Dx, and as Dy in the y-direction. For the
following example, let the total distance traveled at each x-direction boundary crossing
be denoted as X and the total distance traveled at each y-direction crossing as Y. The
total distance traveled can then be calculated by adding the incremental distance traveled
to the last total distance for that dimension. Thus, the total distance traveled at point B is
Dx added to the total distance X traveled at point A. When the particle reaches point C,
the distance Dy is added to the last Y total distance. When point D is reached, Dx is
added to the last calculated value of X, which was the total distance at point B. The same
process occurs for each of the directions. The distance traveled in each univel is the
difference between the total distance for the dimensional boundary crossed and the
overall total distance. The particle tracking ceases when the weight reaches a user-
defined cutoff or the edge of the univel space is reached.
Figure 2. A two-dimensional example of ray tracing through the univel geometry.
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The tallies are calculated on the univel grid defined by the problem geometry or an
integer multiple of this univel grid. A standard track length estimator is used for the
tallies, i.e., each time a particle passes through a univel, the distance that the particle
travels times the weight of that particle is added to the tally in the univel. Tally values at
a point are calculated by quadratic interpolation along the three coordinate axes,
assuming that the value for a univel applies at the centroid of the univel volume. This
interpolation uses the tally values for the univel containing the point and the 26
surrounding univels in 3-space.
The tally statistics estimate the deviation of the calculated tally results from the “true”
results, those derived from an infinitely long calculation. It should be noted that this is
not necessarily how close the answer is to the correct answer, since there are biases in the
data and methods used. There are two extreme ways of calculating the “true” result. The
first is to treat each particle tracked as a single experiment. The second is to treat the
entire run of particles as one experiment. The first method requires statistics computation
for each particle that is tracked. For the first method, the transport code was spending far
more time calculating the statistics than performing the particle tracking. The second
extreme does not give any idea about the precision of the calculation, since the variance
of a single experiment cannot be calculated. The method used in JART allows the user to
define the balance between the frequency of statistical value computation and overall
calculation speed.
The searchlight problem is a classical two-dimensional radiation transport problem
originally proposed by Chandrasekhar (Chandrasekhar 1958). The problem as
considered for this work consists of a homogeneous half-space of material illuminated by
a pencil beam of mono-energetic neutrons normal to the free surface. The solution
assumes no energy dependence of the cross section and only isotropic elastic scattering.
The composition of the half-space is a material with unit total cross section (99%
scattering and 1% absorbing). This provides an excellent problem for testing the basic
mechanics of the Monte Carlo transport, especially the tracking and tally routines.
The reference solution for this work is the analytical solution derived by Ganapol
(Ganapol 1994). Computations were performed for the radial dependence of the flux at
several penetration depths within the half-space. The JART model approximated the
half-space by a rectangular parallelepiped of size 36x36x38 mean free paths (mfp), which
adequately represents an infinite half-space. The univel size used for the calculation was
0.1x0.1x0.1 mfp. The flux as a function of radius was calculated at several different
penetration depths. The JART tallies at each radial point were averaged over the four
points in the primary compass directions to exploit the natural symmetry of the problem,
while the MCNP (Briesmeister 2000) tallies used annular shells for surface (type 2)
tallies.
The results of the JART calculations, along with the reference solution and an equivalent
MCNP calculation, are shown in Figure 3. The tally statistics on the JART and MCNP
results are too small to be resolved on the images. Agreement between the various
methods is excellent and within the calculated tally statistics of the Monte Carlo results.
This provides verification for the correct functioning of the basic transport mechanics of
the JART code.
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The results displayed in Figure 3 required simulation of 32x10
6
particle histories. The
CPU time consumed by the JART calculation was 291 minutes, compared with 161
minutes for the MCNP calculation. Both simulations were run on a single processor Sun
Blade 2000 workstation. The ratio of the computation times of JART and MCNP, which
is less than a factor of two, shows that Java has the capability to perform complex
scientific calculations without an undue penalty in computation time. Because of the
nature of the univel geometry, increased complexity in the problem geometry will have
minimal effect on the JART runtimes, but can greatly increase the runtime for MCNP. It
is possible that JART could have an advantage in computation time over MCNP for
clinical radiotherapy calculations. This will be verified in future investigations.
Figure 3. Comparison of searchlight problem results for several penetration depths.
JAVACAVE
A framework was created to support 3D immersive environments such as an environment
provided by a CAVE
®q or a head mounted display. Immersive environments typically
use stereo projection to create lifelike 3D objects, and surround the user in a virtual
world. The CAVE system surrounds the user by projecting the virtual world onto the
walls and floor of a small room, while the head mounted displays place small screens
right in front of the user's eyes and restricts the user from viewing the outside world.
q
CAVE is a registered Trademark. See: http://www.evl.uic.edu/pape/CAVE/
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JavaCAVE is unique in that it is written almost entirely in Java using the JOGLr (Java to
OpenGL) library. It has a plugin system to abstract interfacing with input devices and the
process of synchronizing frame updates over multiple projectors. A CAVE system
typically has a projector for each wall. In order to provide a smooth, image each
projector has to synchronize its refresh rates and swap the frame buffers at the same time.
JavaCAVE has been designed to work on clusters, where each machine in a cluster is
responsible for one wall. Clusters make sense, since it is less expensive to buy fast PCs
with good video cards then to buy a single visualization server. Of course, it is more
difficult to synchronize the video cards in multiple computers to use the same refresh rate
and swap buffers at the same time. Video card manufactures, such as NVIDIAs, have
graphic cards that can be networked together and configured to synchronize themselves.
JavaCAVE comes with a plugin to properly configure the NVIDIA synchronization
system.
Currently, JavaCAVE is able to display the geometries created in the Model module, and
allows the user to point at regions and change the opacity. Work is being done to
integrate and to display more information, such as the dose contours.
PATIENT MODULE
The patient module was updated to allow the user to associate a picture with a patient. In
addition, a new memory window was added to monitor the memory usage and give the
user more control over the Java garbage collector.
IMAGE MODULE
Most of the Image Module has been rewritten to be faster, more reliable, and have a
smaller memory footprint. User responsiveness has been increased by multithreading
most of the long image operations, thus allowing the user to use other modules while the
Image module is busy. Progress monitors with a cancel option are now displayed for all
actions requiring a noticeable delay. A drag and drop system was implemented that
allows the user to reorder the images by dragging them around the Image workspace, and
the user can build composite image sets by dragging images from one set into another set.
An improved undo system was also developed that records only the actions needed to
revert the user's actions. For example, the action required to undo a horizontal flip is a
horizontal flip. The old undo system worked by saving the old data, which uses much
more memory than the new system.
The restriction that all images must be 15 bits has been lifted, allowing any image from 1
to 15 bits to be used. If an image is 16 bits, then it is scaled down to 15 bits to avoid any
potential problems. The image is down-sampled because Java does not support unsigned
data types. Without unsigned data types, comparisons with 16 bit values become
problematic, since any value over 32,767 will wrap around and become negative.
Adjustment plugins, which allow the user to modify the image color table, were added.
This allows the user to change the brightness, contrast, and gamma of an image set
r
https://jogl.dev.java.net/
s
NVIDIA, Santa Clara CA., www.nvidia.co.uk
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without changing any of the data, since the color table translates the data into the color
displayed on the screen.
The DICOM
t
importer has been improved to be more generic and more reliable allowing
the user to import more images then before, even if the images do not exactly follow the
DICOM specification. Currently, the importer can only import magnetic resonance
images (MRI), computed tomography (CT) images, and X-ray images, but it is generic
enough that it can be extended to import geometries and doses.
MODEL MODULE
The user interface for the Model module has been updated by adding rulers to the main
editing view and by displaying axis information. The rulers can be switched between
English and metric units, and updated depending on the zoom, rotation, and the axis the
user is viewing. The axis graphic also tracks any changes to rotation. In addition, a new
pixel information window was created that provides information about the pixel, such as
region number, name, material name, and location under the user's cursor. In order to
identify undefined pixels, a command was added to jump to the next slice with an
undefined pixel. The user can also change the color of undefined pixels from transparent
to any other color. Finally, the tool plugins can now specify what category they belong
to, and the user interface will visually group them. This displays tools, like the marker
tools, together on the user interface.
ANALYZE MODULE
Most of the changes to the Analyze module have been bug fixes, but there are a few
notable changes. A binary agent editor was added to allow the user to specify and
configure the binary agents before the transport simulations are run. Database access has
been multi threaded to allow the user to work in other modules while the Analyze module
is loading the data. The Contours plugin has been updated to display the markers added
in the Model module.
MTR SOURCE
The MTR Source plugin has been updated with a greatly enhanced user interface. A
wizard now guides the user through a series of steps to make sure that required actions
are performed at the proper times. User entered data is now checked to make sure it is
valid before trying to use it. More error checking has been added when loading data from
the database, and, if the database is missing some information, default values are used.
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INTRODUCTION
Veterinary radiation oncology researchers at the Washington State University (WSU)
School of Veterinary Medicine, with collaborative technical assistance from the Idaho
National Laboratory (INL), have made significant, historical contributions to the
understanding of the in-vivo biochemistry and radiobiology of Boron Neutron Capture
Therapy (BNCT). For example, the large-animal model studies of normal brain tissue
tolerance conducted by this group (Gavin et al. 1994, 1996, 1997), provided a key
component of the radiobiological basis for the resumption in 1994 of human BNCT trials
in the U.S. Those studies used the epithermal-neutron beams available at Brookhaven
National Laboratory and at the Petten facility, in The Netherlands, with technical support
from the INL in several areas of physics, biophysics, and analytical chemistry. In that
work, INL provided experimental neutron dosimetry, computational treatment planning
using specialized software developed for the purpose (Nigg 1994; Nigg et al. 1997) as
well as precision measurements of boron content in various tissues, blood, and urine of
each experimental subject (Bauer et al. 1989, 1992, 1993a, 1993b).
More recently, INL and WSU have collaborated in the construction of a more convenient
and cost-effective epithermal-neutron beam facility for BNCT research and borated
pharmaceutical screening in large animal models on site at WSU (Wheeler and Nigg
1994; Burns 1996; Nigg et al. 2002; Venhuizen 2001, 2002, 2003). The new neutron
beam extraction facility, which will also have a capability to produce a source of thermal
neutrons for small-animal research and cell studies, is now in full-power operation at the
WSU Nuclear Radiation Center.
This article summarizes the construction and current characterization of the full-power
epithermal-neutron beam at WSU. For completeness, previous years’ work related to the
construction of the beamline components is first summarized, followed by a description
of specific accomplishments during 2004, which includes the final wall covering in the
treatment room, as well as initial measurements conducted to verify the thermal neutronic
performance of the beam with the heavy water (D2O) moderator installed in the
collimator.
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FACILITY DESCRIPTION
In the early 1990s, having experienced the considerable logistic difficulties and
transportation expenses that were associated with performing large-animal model
research using the geographically distant Brookhaven Medical Research Reactor, WSU
and INL initiated a feasibility study for construction of a suitable epithermal neutron
beam facility using the existing TRIGA
a
research reactor at the WSU Nuclear Radiation
Center (Wheeler and Nigg 1994). TRIGA research reactors have long been recognized as
suitable neutron sources for BNCT (Whittemore 1992). They have very robust passive
safety features and, in the case of the WSU installation, there is excellent direct access to
the reactor core, facilitating the construction of the required neutron beam extraction
component assembly. Construction of the new epithermal beam facility was completed
in 2003 with the installation of online beam monitoring instrumentation and a major
reconfiguration of the WSU reactor core to optimize the beam intensity.
The 1 MW WSU reactor core is suspended from a movable bridge above the pool as
shown in Figure 1. It can be positioned directly adjacent to a truncated aluminum cone
that extends horizontally into the reactor pool from the tank wall on the upstream side of
the filtering and moderating assembly. This cone and the adjacent thermal column area
were originally filled with graphite, comprising the thermal neutron column (or thermal
column) for the WSU Nuclear Radiation Center. A water-filled shield was located on the
downstream of the graphite thermal column. Figure 2 shows a schematic diagram of the
WSU epithermal-neutron beam facility. The new epithermal-neutron beam extraction
components are located in the thermal-column region of the reactor-shielding monolith.
The original graphite has been removed from this region and replaced with a new
epithermal-neutron filtering, moderating, and collimating assembly as shown. Neutrons
emanating from the core travel into the filtering and moderating region. The spectrum is
tailored in this region such that most neutrons emerge with energies in the epithermal
energy range (0.5 eV – 10 keV). Downstream of the filtering and moderating region is a
bismuth and lead gamma shield, followed by a conical neutron collimator composed of
bismuth surrounded by borated polyethylene. Provision is made for several different exit
port aperture sizes as shown. A heavily shielded concrete beam stop and treatment room
has been constructed just outside of the thermal column opening in the reactor shield wall
as shown in Figure 3.
A key distinguishing feature of the WSU facility is the incorporation of a high-efficiency,
neutron moderating and filtering material Fluental
TM
developed by the Technical
Research Centre of Finland (Auterinen and Hiismäki 1993) into the design. Fluental is
manufactured by hot isostatic pressing of a mixture of 69% (by weight) aluminum
fluoride, 30% aluminum, and 1% lithium fluoride. A block of this material having a
thickness in the beam propagation direction of 0.64 m and transverse dimensions of
approximately 0.6 m is surrounded by aluminum oxide to produce the neutron filtering
and moderating region shown in Figure 2. MCNP (Breismeister 2000) and DORT
(Rhoades 1993) radiation transport design calculations for the coupled core and filter-
collimator assembly indicated that a free-beam epithermal neutron flux of approximately
a TRIGA is a trademark of General Atomics of San Diego, CA.
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10
9
n/cm
2
-s at a reactor power of 1 MW would be produced at the irradiation point (with
the reactor core optimally loaded). The background neutron KERMA rate per unit useful
Figure 1. Elevation plan of the WSU TRIGA reactor facility.
Figure 2. WSU column assembly, with epithermal neutron filter in place.
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epithermal neutron flux (a measure of the fast-neutron contamination) for the beam was
calculated to be approximately 3.0 x 10
-11
cGy/n-cm
2
. The computational methods used
for this design were previously validated against INL measurements performed for a
similar neutron beam facility that is already in operation at the FiR 1 TRIGA research
reactor in Finland (Nigg et al. 1999, 2001).
Figure 3. Approximate WSU beam stop and treatment room arrangement (top view).
An additional key feature of the WSU beam facility design is the provision for adjustable
neutron spectra. The filter-moderator thickness can be changed to systematically explore
the radiobiological consequences of increasing the fast-neutron contamination above the
nominal value associated with the baseline system described above. This is an important
clinical issue for BNCT (Alpen et al. 1993). Thinner filter/moderator arrangements will
produce epithermal beams having correspondingly harder spectra and greater levels of
fast-neutron contamination. The beamline components shown in Figure 2 are designed
for relative ease of disassembly and re-assembly compared to other reactor-based
epithermal-neutron facilities that are currently in operation. Thus, it would be possible to
have a number of different filter/moderator arrangements over the life of the facility. It
should also be noted that provision has been made to fill the collimator region with heavy
water (D2O) to provide an option for a thermalized neutron beam for cell and small
animal studies. This is achieved via a triple-walled plastic liner inside of the collimator,
coupled with a bismuth end cap placed over the collimator exit. Testing of the beam
thermalization components was completed in the latter half of 2004.
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SUMMARY OF BEAMLINE CONSTRUCTION AND INSTRUMENTATION
Construction of the new WSU beam facility began by removing the existing graphite
from the thermal column. In other facility work, sponsored by the State of Washington,
the reactor tank was drained and completely refurbished, and the main heat exchanger
was replaced. In the meantime, the Fluental beamline filter/moderator components were
machined by VTT Finland to INL specifications and delivered to WSU. These
components were first assembled on the reactor floor to verify the dimensions. In
addition, the necessary aluminum oxide beamline components were fabricated by Coors
Ceramics and delivered to WSU.
Beamline Component Installation
Prior to installation of the filter-moderator components, it was deemed necessary to place
thermocouples at selected locations on the primary gamma shielding at the upstream end
of the thermal column cone housing, as shown in Figure 4. This shielding is composed of
lead and is (by design) subject to heavy gamma heating from the adjacent reactor core.
Hence, the temperature must be monitored to verify a suitable temperature margin.
Figure 4. Thermocouple installation in the upstream gamma shielding region of the WSU
thermal column cone.
The primary filter moderator-filter assembly was then built up from blocks of aluminum
oxide and Fluental as shown in Figure 5 for the partially completed assembly and for the
fully completed assembly.
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Figure 5. Partially completed (left) and fully installed (right) WSU filter-moderator
assembly.
Following the installation of the filter-moderator assembly, the concrete walls and ceiling
of the treatment room were constructed. The partially completed treatment room, prior to
pouring of the roof, is shown in Figure 6. During the two-month period of time required
for this part of the project, bismuth blocks for the final gamma shield were fabricated.
Figure 6. WSU treatment room walls during construction.
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Four interlocking bismuth gamma shield blocks were cast at the INL. When the
treatment room was completed and access to the thermal column was again possible,
these blocks were installed as shown in Figure 7. The bismuth bocks, which span the
central part of the filter-moderator, are surrounded by standard lead shielding blocks.
Prior to installing the shield blocks, the entire filter-moderator assembly was covered by
1-mm (40-mil) of cadmium using 30.5 cm (12 in.) vertical strips (also shown in Figure 7)
in order to suppress thermal neutrons in the final beam.
Figure 7. Cadmium thermal neutron shield and bismuth-lead gamma shield during
installation at WSU.
Figure 8 shows the collimator installation. The collimator, comprised of 16 identical
bismuth “barrel-stave” castings to facilitate assembly and disassembly without heavy
lifting equipment, is a truncated right circular cone with a base opening diameter of 91.4
cm (36 inches), a height of 38.1 cm (15 inches), and a wall thickness of 3 cm (1.2
inches). The angle of the cone is 45 degrees. It is supported by borated polyethylene and
two rows of lead bricks as shown in Figure 8b. The downstream end of the collimator is
fitted with a bismuth collar designed to provide a transition from circular shape of the
cone to the square shape required to match with the lead shielding bricks comprising the
final shield wall. The collar will accommodate borated or lithiated polyethylene inserts
having various beam port aperture sizes and field shaping configurations. The staves and
collar were also cast at INL using specialized techniques designed for the purpose.
Finally, Figure 9 shows the positioning of the final lithiated polyethylene neutron
suppression shield on the outer surface of the bismuth-lead shield wall as well as the
beam exit port with a 10-cm aperture shaping plate in place.
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(a) (c)
(b) (d)
Figure 8. Final beam collimator installation at WSU showing the partially installed
collimator (a), the fully installed collimator with square exit port collar and lower borated
polyethylene shielding (b), the upper borated polyethylene shielding (c), and the final
lead shielding (d).
Figure 9. Lithiated polyethylene neutron suppression shield and beam aperture plate
arrangement for the 10-cm diameter beam exit aperture at WSU.
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In early 2004, the ceiling and sidewalls were covered with 1 inch thick natural lithiated
polyethylene (7.5% Lithium-Polyethylene, Thermo-electron Cat. No. 215) to reduce the
reflected neutrons without generating additional gamma radiation. Two fluorescent lights
were added in the upper corners. Figure 10 shows the completed structure. To reduce
activation, no metal fasteners were used in the construction.
Figure 10. Lithiated polyethylene lined walls and ceiling of beam room. Lights are
shown in the corners. Fission chamber cables are also visible in the photo.
The neutron thermalization beamline component was installed and tested in 2004. Since
there are requirements for thermal neutrons for small animal (mice-rats) studies, an
investigation was made to determine a suitable means to thermalize the WSU beam. The
result of the investigation indicated that heavy water (D2O) was the best moderator while
allowing maximum neutron flux at the exit. A polyethylene double-walled bag system
was designed by INL researchers to fit inside the collimator. This double bag was then
inserted in a single wall bag, giving a triple containment system (bags mfg. by Interstate
Plastics, Boise ID). Figure 11 shows the bags inflated with nitrogen prior to installation
in the collimator volume. The ‘top’ is the right hand side of the figure. The fill/drain and
vent hoses (Tygon tubing) are shown coming out the top of the single wall bag.
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Figure 11. Polyethylene bags inflated with nitrogen.
Figure 12 shows the bags installed in the collimator with the hoses and the fission
chamber cables protruding from the opening. Figure 13 shows the hoses and cables
threaded through the bismuth retainer plate. This plate restrains the water filled bags in
the collimator. The bismuth plate is bolted to the collimator collar.
Figure 12. Polyethylene bags installed in the collimator. Tygon fill and vent lines are
shown.
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Figure 13. Bismuth retainer plate with fill/drain hoses inserted.
Figure 14. Bismuth plate installed in collimator opening. Four corner bolts are threaded
into the bismuth collar. Cables are connected to the fission chambers.
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The heavy water was pumped into the bag from two 15-gallon containers. Prior to filling
the bag, the liquid level in the containers was noted so that all the heavy water could be
accounted for when removed from the bag. Since the heavy water becomes tritiated with
neutron exposure, the heavy water was treated as contaminated when it was drained from
the bag. The tritium buildup was calculated to be approximately 1.1x10
-3
microcuries per
milliliter per hour of full power (1 MW) operation. The measured tritium concentration
after one-hour full power operation was 0.93x10
-3
microcuries per milliliter.
On-Line Instrumentation
Because the WSU facility is, at least for the foreseeable future, intended only for animal
studies, it has been possible to achieve some economies by simplification of the online
instrumentation compared to what is required for BNCT facilities used for human trials.
The primary beam monitor is based on redundant fission chambers (GE Reuter-Stokes
Model RS-P6-0402-101) mounted on the inside of the collimator, approximately halfway
between the bismuth shield face and the collimator exit. These chambers were installed
and tested in late FY 2003.
Figure 15. Fission chambers positioned in bismuth shield prior to insertion into the
bismuth collimator. Note the insulation (shrink tubing) on the chambers and MHV
connectors. The Lucite plate keeps the chambers in place.
Figure 15 shows the fission chamber assembly prior to insertion into the collimator. The
cadmium-covered fission chambers were surrounded on the upper side with 5 cm of
bismuth for a gamma shield. Since the chambers are made of aluminum and the
electrical connectors are made of steel, these items, along with the cadmium covers, will
become activated when exposed to neutrons. The bismuth shield was thus provided in
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order to reduce the gamma exposure at the collimator exit due to this activation as well as
from the fission products formed in the chambers themselves. These fission chambers,
operated in current mode, form the basis for an independent online epithermal neutron
monitor not tied to the reactor power measurement.
The electrometers used with the fission chambers are Unidose E made by PTW-Frieburg.
The fission chambers are operated at 250 volts. They can be used to measure current or
can integrate charge for set time periods. There is a provision for continuous monitoring
and data storage by computer via a serial port.
Figure 16 shows the upper side of the fission chamber shield, prior to installation and
after installation on the lower inside surface of the collimator. It was confirmed by
measurement with and without a large Lucite phantom at the exit port that the response of
the fission chambers in this location is insensitive (<2% variation) to the presence or
absence of hydrogenous scattering material at the exit port.
Figure 16. Fission chamber gamma shield prior to (left) and after (right) insertion into
the bismuth collimator.
The incident gamma field in the beam is currently measured using a Radcal Corporation
Model 9010S with a model 10X5-0.6 ion chamber. The ion chamber, which has a 0.6
cm
3
active volume and 1 µGy/min to 74 Gy/min rate sensitivity, is positioned at the exit
plane of the beam when measuring the free-beam gamma dose rate.
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Figure 17. WSU treatment room showing the ambient neutron monitor (Bonner sphere)
in the upper right corner. The neutron beam exit port is to the left in the figure.
The ambient neutron and gamma fields in the treatment room are measured using a
combined neutron-gamma instrument (Ludlum Model 375) composed of a Bonner sphere
surrounding a BF3 chamber, and a separate Gieger-Muller gamma monitor mounted
nearby. Figure 17 shows the location of these instruments in the treatment room. The
epithermal neutron beam port is just inside the thermal column cavity on the left side of
the figure.
Standard Dosimetry Phantom
A Scandtronix clinical water phantom with a 3-dimensional positioning system (Therados
Model RFA-3) was positioned in the beam as shown in Figure 18. This system was
originally developed for calibration of photon therapy machines, and modified for use
with the neutron facility. Only the 3-axis drive and positioning system, water tank, and
position readout are being utilized for neutron measurements. The tank was filled with
de-ionized water. A paired set of tissue-equivalent and graphite ion chambers (Far West
models 784 TTW and 773-TGW, respectively) was installed in the water phantom, and
initial testing of the overall system with the unoptimized neutron beam was completed in
2003. The Unidose-E electrometers were used for the readout. Specifications for this
system are consistent with the recommendations of the International NCT Dosimetry
Exchange (Järvinen and Voorbrack 2003) for a reference dosimetry phantom of this type.
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Figure 18. Water phantom at WSU (left), with detail of paired ion chamber arrangement
(right).
Reactor Core Fuel Reconfiguration
In the final step of the beam installation, the WSU reactor fuel-loading configuration was
modified in late calendar year 2003 to substantially shift the spatial peak of the fission
distribution toward the side of the core immediately adjacent to the epithermal beamline
entrance. Calculations indicated that this would roughly triple the beam intensity.
Figure 19. New core loading pattern (left), compared with previous fuel loading pattern
(right). Yellow squares are standard low-enriched fuel, red squares are high-enriched
fuel, and black squares are graphite reflectors. The epithermal beamline entrance is
adjacent to the left side of both diagrams.
Figure 19 shows the new fuel-loading pattern compared with the previous loading.
Specifications for the new loading pattern were developed by the INL using an MCNP
computational model of the reactor. Independent calculations were performed by WSU
to confirm the results. In general, the desired flux shift was achieved by removing
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graphite reflector elements on the side of the core adjacent to the beamline entrance,
replacing these with low-enriched fuel, and shifting the highly-enriched section of the
core toward the same side. In addition, the startup source was moved to a new position,
away from the beamline entrance as shown, and replaced with highly enriched fuel.
PERFORMANCE VALIDATION FOR THE OPTIMIZED BEAM
Measurements of the free beam spectrum and some in-phantom beam performance
measurements were conducted by INL and WSU at several points during the final
construction phases to establish that the beam performance was within the expected
range. These measurements included simplified neutron foil activation measurements for
the free beam, a few basic phantom measurements using foils and flux wires and, finally,
a free beam measurement based on counting of radiation-induced nucleation sites in
specialized superheated materials (Apfel et al. 1979, Nath et al. 1993) to provide
improved detail in the above-epithermal energy range. These early measurements are
well documented elsewhere (Venhuizen et al. 2001, 2002, 2003) and the details will not
be repeated here. In addition, a visiting representative of the European team of the
International NCT Dosimetry Exchange (Harling et al. 2002) performed some
preliminary independent measurements of the beam in early 2003, prior to the
reconfiguration of the core.
The discussion here will focus only on a summary of the basic free beam measurements
conducted by INL and WSU in late 2003 to confirm the intensity and spectrum of the
final beam after the core fuel reconfiguration was completed. More detailed
characterization measurements are planned for 2005. It is anticipated that these
measurements may also include continued participation of WSU in the International NCT
Dosimetry Exchange (Järvinen and Voorbrack 2003).
The free beam neutron spectrum measurements reported here are for an imaginary
transverse “source plane” passing through the base of the square flange on the
downstream side of the bismuth collimator collar (see Figure 8b). The source plane is a
mathematical construct used for specifying the neutron source boundary conditions for
the various dosimetry and treatment planning computations required to support each
experimental irradiation. By definition, the physical beamline components upstream of
the source plane do not change from one irradiation to the next. Components
downstream of this plane, such as the field shaping plates, can change for each irradiation
and, therefore, are explicitly modeled in dosimetry and treatment planning computations.
Time-consuming beam modeling computations are thus done only once for each
beamline configuration upstream of the source plane, and the results are coupled to the
patient dosimetry computations for each irradiation via a computed boundary condition
specified for the source plane and validated by appropriate measurements.
The measurements were based on a simplified version of an activation foil protocol that
has been adapted for BNCT applications by the INL through extensive experience with
several other epithermal-neutron and fast-neutron facilities worldwide (Harker et al.
1992; Nigg et al. 2000). Standard 12.7-mm diameter cadmium-covered In, Au, W, Mn,
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Co, Cu, and Sc foils were used with a positioning plate made of Lexan
TM
as shown in
Figure 20. An uncovered gold foil was also placed in an outer position of the foil plate.
The foils had nominal thicknesses in the range of 0.0254 mm to 0.127 mm, depending on
the material type.
Figure 20. Source plane activation foil plate (left) positioned in the WSU epithermal
neutron beam source plane (right). The boron sphere is shown in the center of the plate
assembly.
Figures 21 and 22 show an additional aluminum foil wheel that also has been used in
spectrum measurements. This wheel is inserted into the 10 cm exit port of the lithium or
borated polyethylene collimators.
Figure 21. Close-up of the foil wheel without the Cd covers in place.
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Figure 22. Foil wheel assembly layout.
An additional foil was used to provide key spectral information in the energy range above
epithermal (E >10 keV). A heavy (~5 g) 25.4-mm diameter indium foil was placed in a
small hollow boron sphere (inside diameter 2.8 cm, outside diameter 4.75 cm) located in
the center of the foil positioning plate. The composition of the sphere, shown in Figure
23, is approximately 93% 10B and 7% 11B by weight, with a total boron density of 2.6
g/cm3. This arrangement provides essentially total suppression of thermal and epithermal
neutrons within the inner cavity of the boron sphere. Thus, an artificial threshold above
the resonance neutron capture energy range for indium is imposed on the foil within the
sphere. Since the activation gamma emissions that arise from neutron capture in indium
are thereby suppressed, the relatively weak 336 keV gamma line from inelastic scatter in
indium, which is of crucial interest in these measurements, is much more prominent in
the spectrum of the activated indium foil.
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Figure 23. Boron sphere used to suppress low-energy neutron flux.
The irradiated foils were assayed at WSU using a standard high-purity germanium
(HPGe) gamma spectrometry system (Canberra/Genie
TM
). The induced activities in the
free-beam foils were computed from the photopeak areas and system efficiencies based
on calibration of the spectrometer using a National Institute Standards and Technology
(NIST)-traceable mixed europium-antimony calibration source. The measured activity of
the heavy indium foil in the boron sphere was corrected for gamma self-shielding using
an escape fraction at 336 keV calculated using a combination of MCNP computations
and handbook data for the specific source-detector geometry that was used for the assay.
This factor was 0.90±0.01. The measured activation rates of the various foils were then
used to estimate the neutron spectrum by way of an over determined least-squares matrix
unfolding procedure (Nigg et al. 2000).
Figure 24 shows an unfolded 6-group free-field unperturbed neutron spectrum in the
source plane, projected by the unfolding process to the center of the foil positioning plate.
The computed 47-group a-priori neutron spectrum, normalized to 1 MW, is also shown
for comparison. The broad group structure used for calculation of the unfolded spectrum
from the data for the eight activation interactions considered was selected to provide a
well-conditioned unfolding matrix, and to permit an accurate integration of the measured
spectrum in the epithermal energy range to determine the total epithermal neutron flux.
Integrating the measured curve over the epithermal energy range (0.5 eV – 10 keV)
produces a total epithermal neutron flux of 1.66 x 10
9
n/cm
2
-sec at 1 MW with a
propagated uncertainty of approximately 5% (1). An alternate estimate of the measured
spectrum from the activation data using a method based on the SAND-2 code (McElroy
et al. 1967) as described by Draper (1971) yielded a very similar result for the epithermal
flux: 1.54 x 10
9
n/cm
2
-sec. In both cases this is almost exactly three times the flux
produced with the original reactor fuel loading, as expected. This relative intensity
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increase was independently confirmed by on-line fission chamber measurements
performed using the cadmium-covered GE-Reuter-Stokes fission chambers described
previously. Experience with the earlier un-optimized beam showed that the free-beam
flux intensity at the irradiation point is reduced by about 20% relative to the source plane
flux when using the standard 10.16 cm aperture plate. Thus, the useful flux with that
aperture would be approximately 1.3 x 10
9
n/cm
2
-sec, well within the accepted range for
a useful epithermal beam in terms of intensity (Harling and Riley, 2003).
Figure 24. Unfolded free beam neutron spectrum in the source plane obtained by direct
fitting for the WSU epithermal neutron beam facility. The reactor power was 1 MW.
It will be observed that the propagated uncertainty associated with the thermal flux
(E<0.404 eV) in Figure 24 is quite large. This is a result of the fact that the thermal flux
is very small compared to the remainder of the spectrum. The measured activities of the
gold foils with and without Cd covers differ by only a few percent. This leads to a
magnification of the uncertainty in the usual manner when the thermal flux is estimated
from these foil activities in the spectral unfolding process.
A simple, but widely used metric for the biophysical quality of reactor-based epithermal-
neutron beams is based on dividing the free-field neutron KERMA rate of the beam
(integrated over all energies above thermal) by the useful epithermal-neutron flux, again
measured in the free field. This parameter is an indicator of the non-selective neutron
background dose that will be produced in tissue by the above-thermal spectral component
of the beam itself, in the absence of any neutron capture agent that may be administered
to the patient. It is computed here for WSU using the measured flux spectrum in
conjunction with broad group KERMA factors based on data for the components of
standard tissue available on File 27 of the BUGLE (Roussin, 1980) cross section library.
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Fine-group neutron KERMA factors are averaged over the broad unfolding group
structure using the a-priori spectrum as a weighting function to produce the necessary
information. This procedure yields a measured free-beam spectral-average of 2.53x10
-11
cGy total neutron KERMA from all components per unit useful epithermal-neutron flux,
with an estimated uncertainty of about 10%. This is consistent with international beam
design guidelines, and is in excellent agreement with the computed value of 2.75x10
-11
cGy-cm
2
. Approximately 91% of the background neutron dose results from proton
recoil. The remainder is from other recoil components. Additional background dose in
tissue is, of course, produced by non-selective thermal-neutron induced components,
primarily from neutron capture in nitrogen and hydrogen, but these components are not
directly indicative of the intrinsic biophysical quality of the incident beam. They must be
taken into account in treatment planning, but they are not normally included in the free-
beam quality parameter discussed here.
FUTURE PLANS
As noted previously, several measurements of the neutron beam performance were
conducted at various points during the beamline component installation process. These
were basically engineering checks to validate the beam design and to ensure that the
performance was within specification at each point during installation. For example, a
measurement of this type illustrated the need to install an aluminum plate between the
reactor core and the cone entrance, as shown in Figure 25, in order to exclude water from
this region. The gap between the core and the face of the cone was greater than expected
from the design drawings, and the water in this region severely degraded the beam
performance until the plate was installed.
Thus, the types of measurements that have been done so far were for different purposes,
and were less comprehensive than the benchmark characterization measurements that are
needed now that the beam installation is complete. In FY 2005, a more complete set of
characterization and calibration measurements will be documented, following the
guidance of the applicable emerging international standard (Järvinen and Voorbrack
2003). Free beam spectrum measurements using multiple foil techniques, with alternate
methods of spectral unfolding, will be completed for the final beam at the standard
epithermal irradiation location (10 cm aperture, 6.25 cm downstream from the source
plane). Measurements conducted for the thermalized beam will also be completed and
documented. In addition, flux-mapping measurements using activation wires in various
phantoms shown Figures 26 and 27 will be conducted.
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Figure 25. View from above into the WSU reactor tank showing the reactor core on the
left (in the withdrawn position) and the beam entrance cone on the right, with the
aluminum plate in position to exclude water from the region between the core and the
cone face when the reactor is in the position for BNCT irradiations.
Figure 26. Lucite cylindrical and canine phantoms (left) and human phantom (right) used
at WSU. The photo on the left also shows the upstream side of two-beam aperture
shaping plates.
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Figure 27. Lucite cylinder in position for axial flux measurement. Radcal gamma probe
is taped to top of cylinder.
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INTRODUCTION
The Idaho National Laboratory (INL), the University of Washington (UW) Medical
Center, the University of Essen (Germany) Neutron Therapy Clinic, and the Northern
Illinois University (NIU) Institute for Neutron Therapy at the Fermi National Accelerator
Center (Fermilab) have been collaborating on efforts directed toward the development of
supporting technologies required for advanced studies of fast-neutron therapy (FNT) with
concurrent neutron capture (NCT) augmentation (Laramore et al. 1994). In addition to
the development of optimized neutron sources (Nigg et al. 2000), UW, Essen, Fermilab
and INL researchers are conducting measurements to produce suitable benchmark
neutron dosimetry data for validation of advanced three-dimensional treatment planning
methodologies required for successful administration of FNT/NCT.
This experimental effort has included several related components. Free-beam spectral
measurements as well as phantom measurements with Lucite
a
cylinders using resonance
and threshold activation foil techniques have now been completed at all three facilities.
The same protocol was used for all measurements to facilitate inter-comparison of
facilities. The activation results will be useful as a database for further detailed
characterization of the neutron beams of interest as well as for validation of various
explicit neutron transport codes and methodologies for FNT/NCT computational
dosimetry, such as MCNP (Breismeister 2000), SERA (Nigg et al. 1999), and MINERVA
(Nigg 2003).
METHODS AND MATERIALS
To illustrate the types of measurements that have been done, Figure 1 shows the UW
treatment gantry, with the larger of the two Lucite phantoms in position on the patient
couch. This phantom has a diameter of 15.2 cm and a height of 21.6 cm. The smaller
phantom has corresponding dimensions of 12.7 x 18.2 cm. The isocenter of the beam
was located at the center of the top phantom surface.
a
Lucite is a registered trademark of E.I. du Pont de Nemours and Company
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Figure 1. UW neutron therapy treatment facility with the large cylindrical Lucite
phantom in position.
The field size at the isocenter was set to 7.8 cm x 8.0 cm for all irradiations. The
measurements presented here are for the case with the UW “standard” beryllium neutron
production target mounted in the gantry. The proton beam current incident on the target
from the UW cyclotron in the adjacent room behind the gantry was 67 microamperes,
with nominal proton energy of 50.5 MeV. Several different types of foil packages
containing gold, manganese, aluminum, copper, and indium foils, with and without
cadmium covers, were placed at various depths along the central axis of each phantom.
The irradiation time in each case was generally one hour. After the completion of each
irradiation, the induced activities resulting from the various interactions of interest in the
foils were measured by gamma-ray spectrometry, and the results were converted to
saturation activities or, equivalently, activation rates per atom per microampere of proton
current impinging on the neutron production target during the irradiation. Free-beam
spectral measurements have also been completed using various foil packages placed at
the beam isocenter.
Figure 2 shows the fixed horizontal neutron beam facility at UW. The treatment head for
the horizontal beam is of essentially the same design as the gantry-mounted treatment
head. The proton beam from the UW cyclotron can be redirected to the horizontal head
by a system of magnets. The horizontal beam is used primarily for physics
measurements and other non-clinical applications. A specialized neutron production
target, optimized for FNT/NCT applications (Nigg et al. 2000) was mounted in this
treatment head, and all measurements performed for the gantry beam were repeated for
the horizontal beam. This will provide a detailed comparison of the performance of the
FNT/NCT neutron production target relative to that of the standard target.
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Figure 2. Horizontal neutron beam facility at the UW.
Figure 3 shows the Essen treatment gantry, with the larger phantom in place. Once again,
the various measurements were repeated using the same protocol as was used for the UW
measurements. The results will allow a direct inter-comparison of the performance of the
Essen beam (which is produced by a deuteron beam incident on a beryllium target)
relative to that of the two UW beams.
Figure 3. University of Essen Neutron Radiotherapy Facility with INL phantom.
Figure 4 shows a view of the exit port of the Fermilab facility, once again with the larger
of the two phantoms in place. This facility features a fixed beam, with a somewhat
higher energy neutron spectrum produced by 66 MeV protons impinging on a beryllium
target. Patient positioning is accomplished by a chair that has the capability of precise
rotation and translation to produce essentially any beam-patient orientation desired.
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Figure 4. Neutron therapy facility at the Fermi National Accelerator Laboratory
RESULTS AND DISCUSSION
Figure 5 shows some typical results for the two phantoms in the UW gantry beam, as an
illustration of the type of data that is of interest in the overall program. Analysis of data
from all facilities will continue through FY 2005. In the case selected for presentation
here, the activation of manganese with and without cadmium covers is shown as a
function of depth in each phantom. In the case of the bare foils, most of the activation is
due to thermal neutron absorption, and it can be seen that the thermal flux-depth curve is
flatter for the larger phantom. This is as expected, since this phantom is more effective at
thermalizing the higher-energy neutrons in the beam. However, with cadmium covers on
the dosimeter packages, the activation is largely due to resonance neutron absorption at
the primary resonance energy (340 eV) and above in both phantoms, and the curves are
basically the same.
This information, along with information from the numerous other resonance and
threshold interactions in the other foils, allows the development of a self-consistent
picture of the space and energy dependent behavior of the neutron flux within the two
phantoms. This, in turn, will provide benchmark data for validation of neutron transport
computations required for beam characterization and treatment planning. Inter-
comparison of the performance of the neutron beams at the three facilities on a common
basis will also be facilitated.
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Figure 5. Saturation activities for Mn-56 in the small and large phantoms in the UW
gantry beam, without (left) and with (right) cadmium foil covers. Uncertainties are
comparable to the size of the data points shown.
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INTRODUCTION
The National Atomic Energy Commission of Argentina (CNEA) has constructed a
thermal neutron source for possible use in Boron Neutron Capture Therapy (BNCT)
applications at the RA-1 research reactor facility located in Buenos Aires, Argentina.
The Idaho National Laboratory (INL) and CNEA, under a bilateral U.S./Argentina
agreement on peaceful uses of nuclear science, have jointly conducted some basic
physical dosimetric characterization measurements and some limited small-animal
radiobiological dose ranging studies focused on investigation of the potential utility of
this neutron source for neutron capture therapy preclinical research applications. The
experimental protocol for the physical dosimetry included several sets of standard
activation measurements to characterize the neutron spectrum and dose parameters at the
irradiation location, as well as a set of thermoluminescent dosimeter (TLD)
measurements to characterize the gamma field. The radiobiological studies employed a
hamster cheek pouch oral cancer model validated for BNCT studies by CNEA using an
alternate, hyperthermal neutron source available at the RA-6 research reactor in San
Carlos de Bariloche, Argentina (Trivillin et al. 2004; Kreimann et al. 2004). The work
presented here has been motivated by the fact that the RA-1 facility is co-located with the
CNEA radiobiological research laboratories in Buenos Aires, thereby offering some
potential advantages in terms of geographical convenience, cost, and research
productivity.
DESCRIPTION OF THE RA-1 FACILITY
The RA-1 reactor, with a rated operating power of 40 kilowatts, is of the open-tank type
with an enriched uranium (20%
235
U) oxide annular core, moderated and cooled by
demineralized light water, and reflected internally and externally by graphite. The core is
formed by 228 cylindrical fuel rods distributed in five concentric circles as shown in
Figure 1. The outside diameter of the core is 335 mm and the inside diameter is 153 mm.
Each fuel element is composed of a 540 mm UO2 active axial length fuel segment with a
60mm graphite reflector segment on each end. All three axial segments are encapsulated
in 1 mm thick aluminum cladding with an outside diameter of 10 mm.
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Figure 1. View into the RA-1 tank from the top showing the annular lattice of water-
moderated fuel elements.
The reactor is controlled by means of four cadmium rods encapsulated in stainless steel,
located between the core and the external reflector, azimuthally separated from each
other by 90 degrees. The control rods are coupled by electromagnets to drive
mechanisms located in the metal structure above the tank. The drive mechanisms are
powered by stepper motors operated from the control room. A set of sensors constantly
transmits the exact position of each rod.
A transverse sectional view of the reactor and the adjacent graphite thermal column and
shielding structure is shown in Figure 2. To produce the irradiation configuration, a
cavity was made in the previous solid graphite thermal column as shown. This allowed
an irradiation position closer to the reactor core, increasing the neutron flux compared to
the case with the full-thickness thermal column (1600 mm), albeit at the cost of some
decrease in the thermal nature of the spectrum that is produced. A small cart moves in
and out of the cavity, using a system of tracks and pulleys to position the experimental
animals at the irradiation point. This cart is shown in Figure 3. A “shielding box”
constructed from two plates of Lucite
a
with 6 mm of enriched lithium carbonate
sandwiched between them is mounted on hinges connected to the bed of the cart. The
cart is moved into the cavity with the shielding box in the folded position. The box is
then rotated upright on the hinges to position the experimental animals for irradiation.
Figure 4 shows how the experimental animals are positioned in the shielding box, which
is designed for irradiation of two animals at a time. A Lucite hamster phantom is shown
in one of the two available positions. In the case of an actual hamster, the cheek pouch,
i.e. either a normal non-cancerized pouch or a tumor-bearing cancerized pouch, is everted
and spread on the flat surface to the animal’s right. A lithium-Lucite cover plate is then
placed over the hamster. The arrangement allows the cheek pouch to be exposed to
essentially the full thermal flux field at the irradiation point while reducing the thermal
neutron flux in the main body of the hamster via thermal neutron capture in the
surrounding
6
Li, which captures thermal neutrons without producing secondary gammas.
a Lucite is a registered trade mark of E.I. du Pont de Nemours and Company
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Figure 2. Transverse section of the RA-1 reactor and adjacent thermal column, taken
through the core centerline. (Note: Carro = cart, Combustibles = Fuel Elements, Blindaje
= Shielding, Hormigon = Concrete, Agua = Water, Plomo = Lead, Grafito = Graphite,
Colimador = Collimator, Ventana = Window, e = espesor = thickness. All dimensions
are in mm).
Figure 3. Irradiation cart with lithium carbonate lined shielding box in the folded (left)
and upright (right) positions.
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Figure 4. Shielding box with hamster phantom in position, prior to placement of lid.
Figure 5 shows the assembled cart and shielding box positioned at the entrance to the
irradiation cavity in the thermal column. Figure 6 shows a view into the cavity with the
cart in the irradiation position prior to rotation of the shield box. Irradiations are
conducted by bringing the reactor to its rated power of 40 kW, sliding the cart into
position to begin the irradiation, and then withdrawing it to end the irradiation after the
desired time has elapsed.
Figure 5. Irradiation cart with assembled shielding box, positioned at the entry to the
thermal column.
52
Figure 6. View into the thermal column penetration showing the irradiation cart in
position at the irradiation point prior to rotation of the shield box into the upright
position.
PHYSICAL DOSIMETRY
The neutron field characterization measurements were performed using simplified
extensions of neutron activation analysis techniques (Nigg et al. 1999; Harker et al. 1992)
that have been adapted for BNCT applications by the INL through extensive experience
with several other medical neutron facilities in the U.S. and in Europe. Gamma field
measurements were conducted using standard TLDs. Auxiliary neutron transport
computations of various types are also required as part of the experimental protocol. The
various computational and experimental methods used for the RA-1 source
characterization are described in the following sections.
Computational Methods
The a-priori spectrum produced by the RA-1 facility at the irradiation location was
computed using the well-known DORT discrete-ordinates transport code (Rhoades and
Childs 1982) with the BUGLE-80 47-group neutron cross-section library (Roussin 1980).
The reactor and thermal column arrangement shown in Figure 2 was approximately
modeled in two-dimensional cylindrical geometry with the z-axis coinciding with the axis
of neutron flow from the reactor, through the graphite thermalization region and into the
irradiation cavity, i.e., from left to right in Figure 2. This required approximating the
reactor core as a cylinder on its side, but experience has shown that this approximation is
appropriate, provided key region volumes, core reactivity, and key region thicknesses
along the axis of neutron flow are preserved. Additional calculations to determine
spectrum unfolding parameters for the activation measurements were performed using the
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computed flux taken from the DORT model at a transverse plane just upstream of the
irradiation point, coupled with an MCNP (Breismeister 2000) Monte Carlo transport
model of the activation foil and wire packages.
Activation Foil Measurements in the Free Beam
Activation measurements to characterize the free-field neutron source were conducted
using neutronically thick circular foils of various types. The foil specifications and
corresponding neutron activation interactions of interest are listed in Table 1. Because of
the limited time available, a very simple set of foils was used for these measurements.
Nonetheless, useful results were still obtained.
The basic experimental arrangement for positioning the foils in the beam is shown in
Figure 4. Standard 12.7-mm (0.5 inch) diameter gold, copper, tungsten, and indium foils
were placed in the irradiation position occupied by the everted hamster cheek pouch on
the outer surface of the shielding box. A cadmium cover was placed around this set of
foils to suppress the thermal-neutron response. Each cadmium-covered foil thus responds
largely to neutrons having energies at or near the energy of the respective primary
resonance of the foil material, as shown in Table 1. Uncovered gold and manganese foils
were also placed in the irradiation position to permit a measurement of the thermal flux.
The foils had nominal thicknesses in the range of 0.0254 mm (0.001 inch) to 0.127 mm
(0.005 inch), depending on the material type.
Table 1. Activation interactions and foils used in the INL/CNEA measurements.
Neutron
Interaction
Energy Range of
Primary Response
Activation Gamma Energy
of Interest (keV)
55
Mn (n, ) Bare Foil Thermal 847
197
Au (n, ) Bare Foil Thermal 411
115
In (n, ) Cd Cover 1 eV Resonance 1293,1097, and 416
197
Au (n, ) Cd Cover 5 eV Resonance 411
186
W (n, ) Cd Cover 18 eV Resonance 686
63
Cu (n, ) Cd Cover 1 keV Resonance 511 (Positron)
115
In (n, n') Cd Cover 430 keV Threshold 336
The cadmium covered indium foil was also used to provide additional spectral
information in the energy range above epithermal (> 10 keV). In addition to the
prominent gamma lines from
116
In that result from neutron capture in
115
In, there is also a
relatively weak 336 keV gamma line from an isomer of
115
In that is formed by inelastic
scatter. This latter interaction can be used to gauge the neutron flux above the threshold
for this interaction (~400 keV).
Use of the foils as described provided 7 basic neutron response functions having a useful
degree of linear independence. These response functions were:
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1. Resonance capture in the copper, tungsten, gold, and indium foils, all with thermal
neutron capture suppressed by cadmium (4 responses);
2. Total neutron capture in the uncovered gold and manganese foils (2 responses);
3. Inelastic scatter in the cadmium covered indium foil (1 response).
The measurements reported here are based on the results of a one-hour irradiation at a
reactor power of 40 kW.
The irradiated foils were assayed using an Ortec gamma spectrometer system recently
placed into operation at the CNEA reactor laboratory. The system consisted of an high-
purity germanium (HPGe) detector and a a DigiDart
TM
digital gamma ray spectrometer,
coupled with the Gamma Vision
TM
data acquisition and analysis software. This detector
system was calibrated for energy and efficiency using standard traceable sealed gamma
sources available at the CNEA laboratory. The final measured saturation activities for
the foils are presented in Table 2. Some additional independent measurements of the
activation of cadmium-covered gold and indium foils and for a bare gold foil were
performed by the CNEA staff separately from the collaborative measurements performed
by INL personnel. The results of these measurements, also shown in Table 2, serve to
help validate the larger set of measurements performed in the collaboration with INL.
Table 2. Saturation activities for the foils used in the RA-1 free beam spectrum
measurements. Uncertainties are given in parentheses at the 1 level.
Interaction Type
Measured Activation
Rate per Atom (INL)
Measured Activation
Rate per Atom (CNEA)
55
Mn (n, ) Bare Foil 1.96 x 10-15 (3.0%)
197
Au (n, ) Bare Foil 1.86 x 10-14 (3.1%) 1.96 x 10-14 (10.0%)
115
In (n, ) Cd Cover 9.60 x 10-15 (3.2%)
197
Au (n, ) Cd Cover 3.85 x 10-15 (3.1%) 3.53 x 10-15 (11.3%)
186
W (n, ) Cd Cover 2.15 x 10-15 (6.4%)
63
Cu (n, ) Cd Cover 3.89 x 10-17 (6.6%)
115
In (n, n') Cd Cover 3.93 x 10
-18
(13.5%) 3.63 x 10
-18
(8.3%)
Phantom Measurements
Measurements of the thermal and epithermal neutron distribution at various points on the
surface of and within the Lucite hamster phantom were also conducted, primarily to
estimate the effect of placing the hamster in the shielding box, which was designed to
reduce the thermal neutron flux in the main body of the hamster relative to that seen by
the everted cheek pouch on the outer surface of the box, as discussed previously. Figure
4 shows the hamster phantom in position – in an actual animal irradiation the cheek
pouch would be everted to expose the tumors and extended to the hamster’s right in the
photo, with the tumor region placed roughly at the location of the flux wire that can be
seen to the right of the phantom in the photo. The flux wires used for the measurements
reported here were approximately 8 mm in length and 1 mm in diameter. Each wire had
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a mass of approximately 70 mg, and was composed of copper alloyed with 1.55 percent
gold by weight. This provided two linearly-independent activation responses (neutron
absorption in Cu-63 and Au-197) that were used to estimate the flux distribution in and
around the hamster phantom. The activation responses of the wires could also be used to
unfold a two-group (thermal and above-thermal) neutron spectrum at each flux wire
location, but this was not done in the work presented here. Wires were placed at the
irradiation location where the everted cheek pouch would be, as well as in holes drilled at
various points throughout the phantom head and body, and at various locations on the
hamster surface. There were 15 wires in total.
Spectral Unfolding Procedure
The activation rates of the various foils and wires were used to estimate the neutron
spectrum of the RA-1 beam and the fluxes in the water phantom by way of a direct least-
squares unfolding procedure adapted by the INL for this type of measurement and
documented in Nigg et al. (2000).
Results
Table 3 shows the results for a three-group (thermal, epithermal, and fast) neutron flux
spectrum unfolded from the seven foil responses using the direct method described
above. This particular three-group structure was selected for consistency with standard
epithermal-neutron BNCT flux definition conventions. Three-group a-priori fluxes
calculated by integration of the 47-group calculated a-priori flux spectrum over the
energy ranges indicated are also shown. The unfolding procedure produces measured
results that are significantly different from the a-priori flux. The measured fast and
epithermal fluxes are considerably higher and the thermal flux is lower. The measured
thermal flux is, however, consistent with independent results obtained earlier by CNEA
using the gold activation rates shown in the right-hand column of Table 2 and with the
Westcott theory (Westcott 1962) for estimating the flux from the saturation activity. The
significant difference between the computed and measured fluxes in Table 3 indicates
that the approximate models used in this work, while adequate to estimate unfolding
parameters for the initial measurements of interest here, should be updated to represent
the RA-1 system in more detail prior to being used for actual dosimetry and irradiation
planning.
Background neutron dose rates and boron dose rates per ppm boron-10 are also shown in
Table 3. These were computed by combining the measured flux results with kerma
factors for standard tissue developed from the basic kerma data provided in File 27 of the
BUGLE library. About 85% of the neutron background dose is from hydrogen recoil,
and an additional 5% is from nitrogen capture. The remainder is from several minor
components, primarily carbon and oxygen recoil. Finally, Table 3 includes the results of
gamma dose measurements performed independently by CNEA using TLDs located in
the everted pouch position on the shielding box.
56
Table 3. Calculated and measured integral flux parameters for the CNEA RA-1 thermal
neutron source facility at the irradiation point outside of the lithium carbonate shield box.
Uncertainties are given in parentheses at the 1 level. The reactor power is 40 kW.
Quantity
A-Priori
Calculation Direct Unfolding
Iterative
Adjustment
Fast Neutron Flux
10 keV < E < 17.33 MeV
(n/cm
2
-sec)
3.80 x 10
6
4.72 x 10
7
(19.5%) 3.01 x 10
7
Epithermal Neutron Flux
0.404 eV < E < 10 keV
(n/cm
2
-sec)
1.36 x 10
7
5.28 x 10
7
(11.5%) 5.63 x 10
7
Thermal Neutron Flux
E < 0.414 eV
(n/cm
2
-sec)
2.34 x 10
8
1.51 x 10
8
(3.7%) 1.83 x 10
8
Neutron Dose Rate
(cGy/min) 0.569 6.97 4.47
Boron Dose Rate
(cGy/min-ppm
10
B ) 9.34 x 10
-2
6.03 x 10
-2
7.31 x 10
-2
Gamma Dose Rate
CNEA TLD Measurement
(cGy/min)
N/A 1.3 1.3
Figure 7 shows the results of an alternate spectrum estimation procedure based on
adjusting the 47-group a-priori neutron spectrum using an INL implementation of an
iterative adjustment method described by Draper (Draper 1971). This method is a
variation of the approach used in the well-known SAND-II code (McElroy et al. 1967).
It attempts to find a spectrum that reproduces the measured foil responses as closely as
possible by iteratively adjusting the a-priori fine group flux until a satisfactory result is
obtained, as indicated by the behavior of the reduced chi-squared parameter for the fit
and by the absence of further significant change in the adjusted spectrum from one
iteration to the next. During each iteration through the energy groups, the adjustment
factor for the flux in a given group is taken as the weighted sum of the ratios determined
by dividing the measured reaction rate by the computed reaction rate for each foil
response, where the calculated reaction rate for each response is computed using the flux
spectrum from the previous iteration. The weight function is simply the macroscopic
activation cross section for each foil in each group. Typically, only a few iterations
through the energy groups are required to produce a reasonable result using this method.
The a-priori and adjusted fluxes for the RA-1 neutron source are shown in Figure 7.
Once again, the fast flux is increased considerably by the adjustment procedure,
analogous to the results of the direct unfolding method. Integrals of the adjusted fluxes
over the energy ranges for the three-group structure are also included in Table 3. These
are reasonably consistent with the direct unfolding results, although the fast flux is
somewhat lower. This discrepancy is believed to be attributable to high statistical
uncertainties in the fine-group a-priori fast-neutron flux spectrum. These uncertainties
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are reduced considerably when the three-group flux unfolding parameters are produced
for the direct unfolding method by coalescing the fine-group fluxes. As a result,
experience has shown that the direct unfolding results generally can be assumed more
accurate if there are discrepancies of this type.
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Figure 7. Unfolded free beam neutron spectrum obtained by iterative adjustment for the
CNEA RA-1 thermal neutron source facility. The reactor power is 40 kW.
It is also possible to validate the directly-unfolded fast-neutron flux by further examining
the activation rate of the isomeric state of
115
In. Recall that the inelastic scattering
interaction that leads to this state, which decays with the emission of a 336 keV gamma,
has a threshold in the range of 400 keV. Thus, the inelastic scatter interaction rate that is
measured is a direct indicator of the neutron flux above this energy. The two independent
measurements of this interaction rate (Table 2) give very consistent results for RA-1,
roughly 3.75 x 10
-18
interactions/atom-s.
With regard to the phantom measurements, no fluxes were unfolded from the flux wire
activation rates because of the lack of adequate computational models to compute the
required parameters at this stage of the project. However, based on the copper activation
rates measured for the wires it can be estimated that the thermal flux in the parts of the
hamster body that are protected by the lithium shield is in the range of 20-40% of what it
is at the unprotected everted pouch position. This appears consistent with the TLD
gamma measurements performed by CNEA. The gamma dose measured for the parts of
the hamster body protected by the shield was generally about half of that measured for
the everted pouch position. This indicates a reduction in the hydrogen capture gamma
dose rate (proportional to the thermal neutron flux) in the protected regions of the
phantom. The reduction is less than for the thermal flux itself because there is also a
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constant background gamma dose throughout the phantom inside and outside of the
shield box from the incident gamma field from the reactor as well as from capture
gammas in the cadmium and lead shielding in the irradiation cavity.
Using the data from Table 3, one can estimate the total physical (i.e., unweighted) dose at
the irradiation location for a hypothetical, but realistic, case where there is 50 ppm in the
irradiated tissue as follows:
Background Neutron Dose: 6.97 cGy/min (all sources)
Gamma Dose: 1.30 cGy/min (capture + incident)
Boron Dose 3.02 cGy/min
Total 11.29 cGy/min
Thus the background neutron dose is over half of the total and the selective boron dose is
only about 25% of the total in this case. Changes in the RA-1 beam design that are
currently underway will permit a significant improvement in the neutron spectrum.
BIOLOGICAL DOSIMETRY
The radiobiological dose ranging studies involved two types of hamster irradiations. The
first was a limited set of irradiations using the RA-1 neutron source without
administration of a boron agent in order to gauge the background dose from the mixed
neutron-gamma field at the irradiation location. Additionally, a few initial irradiations
were performed using boronated phenylalanine (BPA) as well as a potential alternate
agent for BNCT. This alternate agent, GB-10 (Na2B10H10), may offer some advantages
(Heber et al. 2004), either alone or in combination with the more commonly used BPA.
GB-10 is not new, but interest in its possible use has re-emerged recently because of its
biochemical performance and the development by INL of an improved synthesis
technique for the key precursor, decaborane. GB-10 is a diffusive agent that has been
shown to achieve high (~100 ppm) blood-boron concentrations in human biodistribution
studies without toxicity. This is an improvement over the performance of the other
largely diffusive agent that is currently approved for human studies, borocaptate sodium,
or BSH. Although a large macroscopic tumor/blood differential would not be expected
with GB-10, it may be that microscopic distributions of GB-10 in and around tumor cells
would be more uniform than appears to be the case with BPA. BPA, commonly used in
human NCT trials worldwide, is an active agent that achieves, at least on a macroscopic
scale, a significant tumor/blood differential uptake ratio, but there are questions about
whether the microscopic (cell to cell) distribution is sufficiently uniform to provide
adequate coverage of the target cells. Hypothetically, if GB-10 were administered in
combination with BPA, macroscopic selectivity would be traded against microscopic
uniformity in order to obtain an improved overall optimum coverage of tumor cells. This
means that fewer cells are left with a non-therapeutic level of boron, and potentially also
offers additional mechanisms for tumor control. This hypothesis has been the subject of
the ongoing INL/CNEA collaboration using the RA-6 neutron beam. The study
presented here is intended to gauge the feasibility of extending this collaboration to
irradiations using the RA-1 facility.
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The hamster cheek pouch oral cancer model has been validated for BNCT studies as
noted previously. Successful tumor control and the absence of normal tissue
radiotoxicity have been evidenced by performing in-vivo BNCT mediated by GB-10, and
GB-10 and BPA administered jointly (Trivillin et al. 2004), and BNCT mediated by BPA
alone (Kreimann et al. 2004) using the RA-6 hyperthermal neutron beam. Within this
context, both normal tissue response and tumor control have been extensively
characterized. Thus, the response of the hamster cheek pouch oral cancer model for
different exposure times and irradiation conditions at RA-1 was able to be accessed for
contributions to the characterization of this beam in terms of radiobiological parameters.
The first set of irradiations at RA-1 involved no body shielding and short (10 minutes)
exposures. Six normal hamsters (non-cancerized) were irradiated with beam only, nine
normal hamsters were treated with BPA-BNCT (15.5 mg
10
B/kg body weight) and nine
normal hamsters were treated with GB-10-BNCT (50 mg
10
B/kg body weight). The
response of normal, non-cancerized animals is clinically relevant in terms of assessing
potential radiotoxicity in dose-limiting tissues in animals that will survive long enough to
show long-term effects. Macroscopic analysis and histological evaluation revealed no
radiotoxic effects up to the last experimental time-point evaluated (3 months).
Eight cancerized hamsters bearing 12 tumors were then treated with BPA-BNCT (15.5
mg
10
B/kg body weight) and a 10 minute exposure time, and they exhibited 50% tumor
control (complete remission + partial remission) by 2 weeks post-treatment with no
radiotoxic effects. Three cancerized hamsters bearing 5 tumors were treated with GB-10-
BNCT (50 mg
10
B/kg body weight) and a 10 minute exposure time, and they exhibited
60% tumor control by 2 weeks post-treatment with no radiotoxic effects. These
irradiations revealed that 10 minute exposures resulted in no radiotoxicity, even with
whole body exposure to the beam, coupled with significant tumor control.
The second set of irradiations involved the use of the body shielding box described
above, as well as longer exposure times to examine the degree of protection conferred by
the shielding device, the maximum tolerated exposure time, and the potential tumor
control associated to the varying degrees of radiotoxicity. Four normal hamsters were
irradiated with beam only for 45 minutes and one normal hamster was irradiated with
beam only for 60 minutes. All five hamsters have failed to show radiotoxic effects up to
3-5 months post-irradiation, the last experimental times evaluated. Three normal
hamsters were irradiated with beam only for 75 minutes, and were sacrificed 9 days post-
irradiation due to severe radiotoxicity. One normal hamster was treated with BPA-BNCT
(15.5 mg
10
B/kg body weight) with an exposure time of 45 minutes, and has failed to
show radiotoxic effects up to 3.5 months post-treatment, the last experimental time
evaluated.
Two cancerized hamsters bearing 3 tumors were treated with GB-10-BNCT (50 mg
10
B/kg body weight) with an exposure time of 75 minutes. The animals died at 6 days
post-treatment due to severe radiotoxicity, and exhibited 100% tumor control. Two
hamsters bearing 10 tumors were treated similarly at an exposure time of 45 minutes.
These animals died 6-21 days post-treatment due to severe radiotoxicity, and exhibited
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90% tumor control. Two hamsters bearing 8 tumors were treated with BPA-BNCT (15.5
mg
10
B/kg body weight) with an exposure time of 45 minutes. Some signs of
radiotoxicity were observed coupled with 100% tumor control. One hamster bearing two
tumors was treated with GB-10-BNCT (50 mg
10
B/kg body weight) with an exposure
time of 30 minutes. Thirty days post-treatment it had failed to exhibit radiointroduced
toxicity, and had shown 50% tumor control. One hamster bearing 8 tumors was treated
with BPA-BNCT (15.5 mg
10
B/kg body weight) with an exposure time of 30 minutes.
The animal was sacrificed at 14 days post-treatment due to moderate radiotoxicity.
Tumor control was 50% for this animal.
Despite the small sample assessed, these irradiations suggest that it would not be possible
to perform BNCT mediated by GB-10 or BPA alone at exposure times in excess of 30
minutes without exceeding normal tissue tolerance at RA-1. Within the context of the
data obtained in previous studies at RA-6, the fact that high tumor control is associated
with unacceptable radiotoxicity would suggest a proportionally small boron dose
component associated to excessive background dose at RA-1. The present radio-
biological findings confirm that the background dose causing the radiotoxic effects
observed herein would originate in the fast neutron/gamma dose components, rather than
in the thermal neutron dose component for which the shielding would act as an effective
protection.
The fact that BNCT mediated by the combined administration of GB-10 and BPA
reduces the dose to normal tissue (Trivillin et al. 2004) is particularly interesting in
scenarios such as RA-1 in which a reduction in background dose is particularly
contributory. Within this context, further RA-1 optimization studies on BNCT mediated
by GB-10 + BPA are warranted within the context of escalating the dose to tumor
without exceeding normal tissue tolerance.
DISCUSSION
The RA-1 facility is the second neutron source specifically constructed for NCT research
in Latin America, and one of only about 12 such facilities currently operational in the
world. The results presented here provide an initial assessment of the performance of this
neutron source using simple but reliable experimental techniques. The results show that
the neutron flux intensity is sufficient for meaningful research applications, but that the
spectrum is currently not optimal. However, improvements are underway that should
increase the thermal neutron flux (and thus the selective boron dose component) relative
to the background fast and epithermal neutron flux and the resulting nonselective
background dose.
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